Filing Details
- Accession Number:
- 0001209191-10-007985
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-09 12:00:00
- Reporting Period:
- 2010-02-05
- Filing Date:
- 2010-02-09
- Accepted Time:
- 2010-02-09 19:35:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1362822 | Matthew Onaitis | Somaxon Pharmaceuticals, Inc. 3830 Valley Centre Drive, Suite 705-461 San Diego CA 92130 | Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-02-05 | 25,000 | $1.23 | 25,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-02-05 | 12,400 | $1.23 | 37,400 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-02-05 | 6,666 | $1.23 | 44,066 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-02-05 | 15,934 | $1.23 | 60,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-02-05 | 60,000 | $3.03 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Acquisiton | 2010-02-05 | 25,000 | $0.00 | 25,000 | $1.23 |
| Common Stock | Common Stock | Acquisiton | 2010-02-05 | 12,400 | $0.00 | 12,400 | $1.23 |
| Common Stock | Common Stock | Acquisiton | 2010-02-05 | 6,666 | $0.00 | 6,666 | $1.23 |
| Common Stock | Common Stock | Acquisiton | 2010-02-05 | 15,934 | $0.00 | 15,934 | $1.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2016-05-14 | No | 4 | M | Direct | |
| 12,400 | 2017-01-16 | No | 4 | M | Direct | |
| 6,667 | 2017-03-01 | No | 4 | M | Direct | |
| 34,066 | 2018-02-18 | No | 4 | M | Direct |
Footnotes
- This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- 27,770 shares of common stock subject to the option are vested and exercisable as of 2/5/2010 and approximately 1,388 shares vest and become exercisable on the first day of each month until June 1, 2011.
- Not applicable.
- 13,770 shares of common stock subject to the option are vested and exercisable as of 2/5/2010 and approximately 688 shares vest and become exercisable on the first day of each month until June 1, 2011.
- 7,404 shares of common stock subject to the option are vested and exercisable as of 2/5/2010 and approximately 370 shares vest and become exercisable on the first day of each month until June 1, 2011.
- 27,770 shares of common stock subject to the option are vested and exercisable as of 2/5/2010 and approximately 1,388 shares vest and become exercisable on the first day of each month until June 1, 2011.
Billionaire Hedge Funds
